Introduction
The Department of Biomedical Informatics is a cutting-edge convergence study that develops new technologies and innovative new drug materials necessary for the prevention and treatment of various human diseases, including COVID-19 and infectious diseases, by combining the biomedical field with bio-big data technology. To foster professional and global talents necessary for the biomedical industry.
Educational goals
- Nurturing convergence-type talents leading the future pharmaceutical industry through multidisciplinary knowledge
- Cultivating creative professional talents through on-the-ground practical knowledge in the cutting-edge biomedical field
- Nurturing glocal experts through collaboration with local and global communities
Careers
- Domestic and foreign pharmaceutical companies, pharmaceutical research institutes, bio artificial intelligence companies, and bio venture companies in the field of drug development using biomedical big data technology
- National research institutes and state-affiliated institutions in the field of biomedical life.
- Graduate school admission at a global university